Page last updated: 2024-11-12
himeic acid a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
himeic acid A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11774903 |
| CHEMBL ID | 2046773 |
| SCHEMBL ID | 23760360 |
| MeSH ID | M0483975 |
Synonyms (5)
| Synonym |
|---|
| himeic acid a |
| CHEMBL2046773 |
| (e)-11-[5-[[(3s)-3-carboxybutanoyl]carbamoyl]-4-oxopyran-2-yl]undec-10-enoic acid |
| himeic acid a_120102 |
| SCHEMBL23760360 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID670508 | Inhibition of GST-tagged ubiquitin binding to FLAG-tagged E1 at 50 uM after 20 mins by immunoprecipitation analysis | 2012 | Bioorganic & medicinal chemistry, Jul-15, Volume: 20, Issue:14 | Hyrtioreticulins A-E, indole alkaloids inhibiting the ubiquitin-activating enzyme, from the marine sponge Hyrtios reticulatus. |
| AID727133 | Inhibition of FLAG-tagged human recombinant UAE-catalyzed UAE-Ub thioester intermediate formation immunoblotting analysis | 2013 | Journal of medicinal chemistry, Mar-28, Volume: 56, Issue:6 | Exploring a new frontier in cancer treatment: targeting the ubiquitin and ubiquitin-like activating enzymes. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.16
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.16) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||